60 results
8-K
EX-3.2
JNCE
Jounce Therapeutics Inc
4 May 23
Termination of a Material Definitive Agreement
7:22am
receive such compensation, if any, for their services on the Board of Directors and its committees, and such reimbursement of expenses, as may be fixed
8-K
EX-3.1
JNCE
Jounce Therapeutics Inc
4 May 23
Termination of a Material Definitive Agreement
7:22am
reimbursement.
9. Subsequent Amendment. No amendment, termination or repeal of this Article SIXTH or of the relevant provisions of the General
SC TO-T/A
EX-99
JNCE
Jounce Therapeutics Inc
25 Apr 23
Third party tender offer statement (amended)
6:07am
. The Depositary and Paying Agent and the Information Agent will receive customary compensation, reimbursement for reasonable out-of-pocket expenses
SC 14D9
JNCE
Jounce Therapeutics Inc
6 Apr 23
Tender offer solicitation
2:51pm
the value of the reimbursement of health care premiums that would be due to the named executive officer pursuant to a qualifying termination
SC TO-T
EX-99
jf7y6vhnle
6 Apr 23
Third party tender offer statement
2:11pm
8-K
EX-1.1
x13ucp5rdt912uennsk
4 Nov 21
Entry into a Material Definitive Agreement
4:21pm
424B5
46aheu
4 Nov 21
Prospectus supplement for primary offering
4:17pm
8-K
y9u2m
15 Sep 21
Departure of Directors or Certain Officers
8:10am